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Intervention coverage—the proportion of the population with a health-care need who receive care—does not account 
for intervention quality and potentially overestimates health benefits of services provided to populations. Effective 
coverage introduces the dimension of quality of care to the measurement of intervention coverage. Many definitions 
and methodological approaches to measuring effective coverage have been developed, resulting in confusion over 
definition, calculation, interpretation, and monitoring of these measures. To develop a consensus on the definition 
and measurement of effective coverage for maternal, newborn, child, and adolescent health and nutrition (MNCAHN), 
WHO and UNICEF convened a group of experts, the Effective Coverage Think Tank Group, to make recommendations 
for standardising the definition of effective coverage, measurement approaches for effective coverage, indicators of 
effective coverage in MNCAHN, and to develop future effective coverage research priorities. Via a series of 
consultations, the group recommended that effective coverage be defined as the proportion of a population in need of 
a service that resulted in a positive health outcome from the service. The proposed effective coverage measures and 
care cascade steps can be applied to further develop effective coverage measures across a broad range of MNCAHN 
services. Furthermore, advances in measurement of effective coverage could improve monitoring efforts towards the 
achievement of universal health coverage.
Introduction
Universal health coverage is at the centre of Sustainable 
Development Goal (SDG) 3: “to ensure healthy lives and 
promote wellbeing for all, at all ages”, and is described as 
the key driver for achieving health-related targets.1
Monitoring progress towards achieving universal health 
coverage requires metrics that capture infor mation on the 
proportion of the population in need of care that receives 
health services at a sufficient level of quality to yield the 
intended health benefits. Effective coverage adds the 
dimension of quality of care to the measurement of 
intervention coverage and aims to better capture the 
potential health benefits of an intervention.2 However, 
despite the potential of the effective coverage approach 
to overcome some of the limitations of inter vention 
coverage, consensus has not been reached on its defi-
nition, methodological approaches for measure ment, 
and how indicators of effective coverage should be 
interpreted to inform global monitoring and national 
programmes and policies. This variability in definition 
leads to confusion as to what actions should be taken 
to monitor and improve quality of care. Due to varying 
approaches to estimate effective coverage, the data used 
to measure effective coverage vary greatly from self-
reported population surveys, surveys with bio markers, 
observations, facility surveys, and routine data collected 
through the Health Management Information Systems. 
Although the data used to estimate effective coverage 
often depend on the concept being measured (eg, content 
of visit, readiness of health-care facility to provide care), 
sometimes the same concepts use different data sources. 
Standardi sation of methods to measure effective coverage 
is urgently needed to ensure that health programmers 
and policy makers can take informed actions to improve 
quality of care for maternal, neonatal, child, and 
adolescent health and nutrition (MNCAHN).
In 2019, WHO and UNICEF convened a group of 
experts, the Effective Coverage Think Tank Group, to 
establish standardised definitions and measurement 
approaches for effective coverage, initiate discussions 
on effective coverage indicators for MNCAHN, and to 
develop priorities for future research on effective cover-
age. The Effective Coverage Think Tank series included 
four video tele conferences, between March and 
April, 2019, and an in-person meeting in May, 2019. 
Participants included 98 experts in the fields of quality-
of-care measurement, monitoring and evaluation, epi-
demiology, and research. They were selected to be both 
geographically diverse and include content expertise 
across the range of MNCAHN components. Participant 
inputs were solicited in advance of each video tele-
conference through a combination of group email 
correspondence and online survey tools. Participation 
was moderated through online video conferencing, 
with a record of each call saved at its completion. The 
in-person meeting was hosted by WHO and UNICEF 
and included a representative group of experts selected 
according to the same criteria described above. The 
purpose of the meeting was to synthesise the experience 
from the video teleconferences and make recom-
mendations for defining and measuring effective 
coverage. This Health Policy paper summarises the 
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discussion and recommendations from the Effective 
Coverage Think Tank Group.
Findings
Evidence synthesis
We examined scoping and systematic reviews on 
effective coverage frameworks, including a recent 
scoping review of effective coverage applications3 
and systematic review of effective coverage in MNCHN.4 
In the scoping review, Jannati and colleagues3 searched 
seven databases for publications on effective cover-
age applications for assessment of health-system 
performance published before May, 2017, with no start 
date restriction, and identified 18 studies, four of which 
examined effective coverage of the health system as a 
whole and 14 assessed effective coverage for specific 
interventions. In their systematic review, Amouzou and 
colleagues4 restricted their focus to applications of 
effective coverage in MNCAHN and reproductive 
health. They identified 36 studies published between 
January, 2000, and October, 2017, 30 of which were 
not included in Jannati and colleagues’ scoping review, 
and highlighted the considerable variability between 
studies relating to data sources for effective coverage, 
indicator definitions, and analytical approaches. We 
shared our findings (panel 1) with Effective Coverage 
Think Tank experts, providing a common background 
for discussions.
Recommendations for health-service coverage cascades 
and terminology
Participants recommended that effective coverage be 
explained using health-service coverage cascades applied 
at the population level. Cascades provide a tool for 
assessing health-system performance across the 
sequence of interactions between patients and the health 
system.9 The generic cascade proposed by Amouzou and 
colleagues,4 which builds on the Tanahashi framework10 
for evaluating health-service coverage and allows for 
population-level assessment of health services along the 
MNCAHN continuum of care, was supported by Effective 
Coverage Think Tank participants for its flexibility to 
adapt across a range of health services.
 The Think Tank Group proposed the following 
adaptation of Amouzou and colleagues’ cascade steps 
(figure 1) and their definitions, with illustrative examples 
for MNCAHN interventions. Step 1 is the target 
population: identifying the population with a specific 
health need. Step 2 is service contact coverage: the 
proportion of the population in need who come into 
contact with the (relevant) health service. Step 3 is input-
adjusted coverage: the proportion of the population in 
need who come into contact with a health service that is 
ready to provide care. Readiness requires that all inputs 
necessary to provide the service are available in sufficient 
quantity and quality and are usable at the time of the visit. 
The specific components will vary with the service and 
the context in which it is provided (eg, health facility, 
community, school). Step 4 is intervention coverage: the 
proportion of the population in need who come into 
contact with a service that is ready and that receives the 
service. Step 5 is quality-adjusted coverage: the proportion 
of the population in need who come into contact with a 
service that is ready and that receives the service according 
to quality-of-care standards. Quality-of-care standards 
constitute what is expected to be delivered to maximise 
the potential positive health outcome and are commonly 
measured by assessing the content of the health service 
relative to guidelines (eg, WHO guidelines).11–14 Meeting 
these standards implies that the necessary practices have 
been followed while unnecessary or harmful practices 
have been avoided (eg, unnecessary antibiotic use). 
Furthermore, quality of care extends beyond adherence to 
guidelines to also consider whether the service was 
provided respectfully.15 Step 6 is user adherence-adjusted 
coverage: the proportion of the population in need who 
receives the service according to quality-of-care standards 
and that adheres to provider instructions. For newborn 
babies and young children, this adherence includes 
caregiver adherence to provider instructions. This step 
might not apply to services that require no additional user 
action after they have been delivered (eg, vaccination). 
Finally, step 7 is outcome-adjusted coverage: the 
Panel 1: Examples of effective coverage definitions and measurement approaches
Effective coverage has been variously defined or measured:
• As the fraction of possible health gain an individual with a health-care need can 
expect to receive from the health system, formalised as a combination of need, use, 
and quality2
• By adjusting intervention coverage levels according to service readiness,5 quality of 
care provided,6 or health outcomes achieved7
• As a single indicator of overall health-system performance, calculated as a composite 
measurement of coverage across a range of interventions8
Figure 1: Proposed standardised cascade for measuring effective coverage
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proportion of the population in need who receives the 
service according to quality-of-care standards, adheres to 
provider instructions, and has the expected health 
outcome. For curative interventions, a positive health 
outcome is assessed by a return to good health, while a 
positive health outcome for preventive and promotive 
services is the absence of health loss.
Recommendations for MNCAHN effective coverage 
definitions and measures
Recommendations from the Think Tank participants for 
the definition and measurement of effective coverage 
are shown in panel 2. Several considerations are 
important when selecting effective coverage measures 
and devel oping cascades. First, measuring effective 
coverage through quality-adjusted or outcome-adjusted 
coverage without reporting the additional steps of the 
associated cascade might be best suited for global and 
national monitoring because it provides an overall 
impression of effective coverage in a country. Second, 
the full cascade is most relevant for monitoring at 
subnational and facility levels, which might need 
detailed information to identify bottlenecks in service 
provision for determining appro priate remedial actions.16 
Third, the level at which data are analysed should also be 
consistent with their intended use. For example, district-
level cascades and their assessments could appropriately 
inform decision making at the district level but might 
not always be suitable for making targeted changes 
at each individual facility within the district. Finally, 
a distinction should be made between what can be 
currently measured given data availability and tech-
niques for linking data sources, and what could ideally 
be measured in the future if investments are made in 
the effective coverage research agenda and in-country 
health information systems.
Potential data sources proposed for effective coverage 
measures
Wherever possible, effective coverage measures should 
rely on validated data. A combination of data sources 
might be necessary to calculate indicators (eg, health 
facility assessments, household surveys, and routine 
Health Management Information System and admini-
strative data). For example, a household survey might 
collect the epidemiological data necessary to quantify the 
target population (eg, incidence, prevalence) while also 
collecting data on care-seeking behaviours for estimating 
service contact and receipt of services necessary for 
estimating intervention coverage. These data could be 
combined with health facility assessment results to 
estimate input-adjusted coverage and potentially quality-
adjusted coverage if the health facility assessment 
included direct observation of services. Although data on 
user adherence are generally more challenging to obtain, 
such data might be estimated according to reported data 
from similar settings. Finally, outcome data might be 
collected through disease surveillance or population-
based surveys. These illustrative data sources provide an 
example of how cascade steps might be assessed. 
However, selecting ideal data sources depends on the 
service for which effective coverage is being assessed. 
Additional considerations regarding potential data 
sources for effective coverage measures have been 
published elsewhere.3,4,17,18
Applying effective coverage and health-service 
coverage cascades to MNCAHN
The Effective Coverage Think Tank Group developed 
several example cascades for MNCAHN to show how 
effective coverage should be applied.
Panel 2: Recommendations from the Effective Coverage Think Tank Group for 
definition and measures of effective coverage for maternal, newborn, child, and 
adolescent health and nutrition
• Effective coverage is defined as the proportion of a population in need of a service that 
had a positive health outcome from the service
• Effective coverage is ideally measured as outcome-adjusted coverage in the health-
service coverage cascade; this type of measure is potentially feasible to produce when 
a target population needs a specific health service with proven effectiveness and for 
which the health impact can be directly linked to the specific service—eg, children 
living with HIV requiring antiretroviral therapy and with viral load suppression
• For routine preventive or promotive health services, such as counselling services, or 
antenatal and postnatal care visits during which multiple interventions are delivered, 
each of which might be linked to the same or different health outcomes, outcome-
adjusted coverage is not an ideal effective coverage measure; a more amenable measure 
for these health services is quality-adjusted coverage, which might be a proxy (indirect) 
measurement of effective coverage; quality-adjusted coverage measures can capture 
information on the timeliness, content, and quality of the health service provided based 
on guidelines and recommendations
• Quality-adjusted coverage might also serve as a proxy for effective coverage in cases 
where outcome-adjusted coverage could potentially be measured but the added value 
of these data is outweighed by the resources necessary to obtain them (eg, immune 
response resulting from vaccination that is complicated by challenges attributing such 
a response to vaccination rather than pathogen exposure)
• Mortality measures are generally not a substitute for measuring effective coverage for 
several reasons—eg, mortality often results from a combination of factors, many of 
which are outside the health system and aggregated mortality cannot be used to 
identify where the health system has failed; we also recognise that substantial data 
gaps exist for cause-specific mortality data (eg, case fatality rates)
• Under a few circumstances, mortality measures might be used to measure effective 
coverage when the cause of death is directly attributable to (the absence of) a specific 
health service—eg, the incidence of intrapartum stillbirth (occurring during the labour 
and childbirth period) has been used as a measure of effective coverage of intrapartum 
care; also, when the incidence and mortality of lethal conditions with known 
treatments are tracked (eg, some cancers are monitored through cancer registries), 
use of mortality-to-incidence ratios might be possible (eg, to assess the health impact 
or benefit of cancer screening and treatment programmes)
Whether effective coverage is measured directly through outcome-adjusted coverage or 
indirectly through quality-adjusted coverage as a proxy, effective coverage is represented 
by a single point along the cascade rather than as the entire cascade itself
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Example in maternal and newborn health
For routine antenatal, childbirth, and postnatal care, 
quality-adjusted coverage is the preferred measure of 
effective coverage (figure 2) because of the challenge of 
attributing maternal and neonatal mortality across these 
services. However, for complications, outcome-adjusted 
effective coverage would be an appropriate measure. 
Because measurement of all complications is not practical, 
a tracer complication can be selected—eg, for post-partum 
haemorrhage, the outcome-adjusted coverage measure of 
controlled post-partum bleeding could be used.
Example in child health
The discussion of effective coverage for child health 
included interventions for both well children, including 
children with disabilities (prevention of disease, 
promotion of growth and development), and sick or 
injured children (treatment of acute and chronic diseases 
and injuries).19 Each of these domains includes a suite of 
interventions. A separate cascade and measurement 
of effective coverage could be developed for each 
intervention; however, resource limitations in different 
contexts would make tracking of effective coverage of all 
interventions simul taneously impractical. When multi ple 
interventions are delivered through the same platform 
(eg, Integrated Management of Childhood Illness20 or 
Integrated Community Case Management21), selection of 
one intervention as a tracer for the overall contact might 
be appropriate.
Quality-adjusted coverage was the preferred effective 
coverage measure for care of a sick child (acute or chronic 
illness), prevention of disease, and promotion of growth 
and development. This choice reflects the challenge of 
attributing contributions of several interventions to a 
single health outcome of child survival or wellbeing. 
Additionally, given the strong association between 
delivering some high-quality interventions and sub-
sequent positive health outcome (eg, immunisations and 
Figure 2: Health-service coverage cascade for routine childbirth care
Figure 3: Health-service coverage cascade for growth monitoring, promotion, and treatment of malnutrition in children
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seroconversion), quality-adjusted coverage can be a 
suitable proxy for outcome-adjusted coverage.
A cascade for growth monitoring and treatment 
of malnutrition in children is shown in figure 3. 
The cascade includes a measure of outcome-adjusted 
coverage, but given the issues discussed here, a quality-
adjusted coverage measure could also be appropriate.
Example in adolescent health
The approach to measuring effective coverage for 
adolescent health differs from the previous two groups 
because many interventions in adolescent health are 
delivered outside of the formal health system or not on an 
individual basis. The Think Tank Group selected 
interventions from among those delivered either through 
the health or school-based programmes and identified 
them on the basis of the burden of disease. One 
intervention selected was vaccination of adolescent girls 
aged 9–14 years against human papillomavirus. A cascade 
for this intervention is shown in figure 4.
Discussion
The outcomes of the Effective Coverage Think Tank 
Group are a step towards improving effective coverage 
measurement and our ability to assess health outcomes 
of proven interventions. At the global level, these 
recommendations on effective coverage will inform efforts 
to improve the universal health coverage service coverage 
index—the official measure for SDG indicator 3.8.1,22,23 
which has been criticised for not including measures of 
effective coverage.
The proposed health-service coverage cascade has four 
important caveats. First, the cascade does not explicitly 
account for the range of underlying reasons for gaps that 
might occur between identifying the target population 
in the first step of the cascade and the second step 
that captures who sought or received needed care. These 
reasons can include a mixture of additional demand and 
supply factors.24–26 If this gap is large, it should trigger 
further investigation into causal factors. Second, adjust-
ment for user adherence is challenging to measure. Poor 
adherence to prescribed treatment can result in poor 
outcomes; however, many factors outside the health 
system can affect adherence. Third, the cascade does not 
include user experience as its own component. User 
experience is a measure of quality of care, yet measuring 
it is difficult and prone to bias.27 Finally, the cascade 
assumes that each step must occur to have the maximum 
positive health outcome. Notable exceptions exist in 
which a positive health outcome might occur in the 
absence of any health service (eg, recovery from illness or 
malnutrition in the absence of any treatment) or when 
the health service does not meet quality-of-care standards 
(eg, a healthy woman and neonate after a childbirth 
without a skilled birth attendant present).
The Effective Coverage Think Tank Group identified 
several research priorities. First, increased efficiency in 
the use of traditional data sources is required while also 
considering the potential for alternative data sources. 
Household surveys and health facility assessments 
provide valuable data; however, these instruments are 
administered only every 3–5 years, and have historically 
focused on women of reproductive age and children 
younger than 5 years for health-related issues. Further 
research is needed to determine how alternative data 
sources might effectively be used to complement these 
traditional data sources. These sources might include 
routinely collected administrative or Health Management 
Information System data, sentinel surveillance sites, or 
the growing body of data collected through innovative 
Figure 4: Health-service coverage cascade for HPV immunisation in girls aged 9–14 years 
HPV=human papillomavirus. NA=not applicable.
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mobile health approaches.28 Because a single data 
source is unlikely to provide information on all steps in 
the cascade, improved coordination across data collection 
approaches and standardised methods and guidance for 
combining data from multiple sources are needed.29–31
Second, new approaches are required to improve the 
availability, validity, and reliability of data for measuring 
each step of the cascade. Examples include being able to 
identify specific target populations, such as preterm new-
born babies requiring kangaroo mother care, because 
not all preterm newborn babies might be stable enough 
to initiate care. Capturing information on less tangible 
components of quality of care (eg, provider norms 
and attitudes) that affect demand issues, such as an 
individual’s willingness to initially seek care and to stay 
in treatment if needed (step 2 of the cascade), is also a 
challenge.
Third, research is needed to understand the linkages 
between the steps in the cascade, which is especially 
important when measuring quality-adjusted coverage. 
National guidelines for service provision often include 
several activities that should be done during a visit, the 
monitoring of which might not be feasible in resource-
limited locations. Defining the subset of activities most 
linked with a health outcome will minimise the additional 
reporting burden while maintaining the usefulness of the 
measurement. Similarly, research is needed to understand 
and capture the resulting health effects when unnecessary 
or excessive practices are performed (eg, caesarean section 
without indication).
Fourth, implementation research is needed to ensure 
that the effective coverage frameworks proposed are 
responsive to the needs of decision makers and provide 
actionable information at the global, regional, national, 
and subnational levels and to determine what tools and 
capacity strengthening are needed in countries to collect, 
analyse, and use these data.
Finally, testing will help to further refine both effective 
coverage indicators and cascade steps, and to assess 
feasibility of measurement. As much as possible, these 
studies should assess inequalities in effective coverage by 
stratifying by key demographic variables. These stratified 
analyses should high light the relevance of effective 
coverage in both low-income and high-income settings, 
where persistent inequities in health-service delivery 
remain.
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